Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05771883
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-24
First Post:
2023-03-06
Brief Title:
A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide
Sponsor:
ImmuneOnco Biopharmaceuticals Shanghai Inc
Organization:
ImmuneOnco Biopharmaceuticals Shanghai Inc
Organization Data
Organization:
ImmuneOnco Biopharmaceuticals Shanghai Inc
Class:
OTHER
Study ID:
IMM0306-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ImmuneOnco Biopharmaceuticals Shanghai Inc
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None